The clinical misdiagnosis rate with qPCR based comprehensive chromosomal screening (CCS) for embryonic aneuploidy is low and may commonly reflect mosaicism

      Class I data have demonstrated that CCS provides meaningful increases in implantation and delivery rates while reducing multiple gestations. Optimal counseling regarding CCS requires discussion of both enhanced outcomes and the clinical misdiagnosis rate. This study seeks to determine the clinical misdiagnosis rate with qPCR based CCS.
      To read this article in full you will need to make a payment


      Subscribe to Fertility and Sterility
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect